Reva Medical Inc. will begin distributing its coronary and peripheral bio-resorbable scaffold devices after Boston Scientific did not renegotiate its agreement and allowed it to expire. Boston Scientific previously held exclusive rights to negotiate distribution, per the 2007 agreement.